Urology · Lexington, KY
NPI
1174622120
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1401 Harrodsburg Rd, C215
Lexington, KY, 40504
Phone (859) 258-6450
Groups this clinician bills Medicare through
Medicare paid, 2024
$331K
19,624 services
Medicare patients, 2024
1,342
Average age 75
Drug cost, 2024
$1.3M
5,397 prescriptions
Company payments, 2025
$62K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas K Slabaugh Jr. was code J1071 (injection, testosterone cypionate, 1 mg), 10,300 times for 12 patients. In total Thomas K Slabaugh Jr. billed 19,624 services in 98 codes, and Medicare paid $331K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-21.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 10,300 | 12 | $0.02 | $230 |
| 99213 Office E&M - Established | Office | 1,646 | 1,067 | $56.80 | $93K |
| 81003 Clinical Chemistry | Office | 1,577 | 1,058 | $2.16 | $3,413 |
| 84153 Clinical Chemistry | Office | 441 | 349 | $17.75 | $7,829 |
| 36415 Venipuncture Blood Collection | Office | 432 | 345 | $8.65 | $3,737 |
| 99203 Office E&M - New | Office | 249 | 249 | $65.83 | $16K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 248 | 29 | $138.23 | $34K |
| 51798 Ultrasound - Nonspecific | Office | 197 | 170 | $7.01 | $1,381 |
| 52000 Cystourethroscopy | Facility | 132 | 120 | $57.18 | $7,548 |
| 76942 Ultrasound - Nonspecific | Facility | 64 | 64 | $22.33 | $1,429 |
| 99221 Hospital E&M - Initial | Facility | 63 | 60 | $61.07 | $3,848 |
| 55700 Other Organ Systems | Facility | 60 | 60 | $96.29 | $5,777 |
| 96372 Injection Administration | Office | 59 | 20 | $9.75 | $575 |
| 99214 Office E&M - Established | Office | 58 | 56 | $86.24 | $5,002 |
| 99231 Hospital E&M - Subsequent | Facility | 51 | 22 | $37.23 | $1,899 |
By year: 2022 $343K for 19,727 services; 2023 $329K for 14,317 services; 2024 $331K for 19,624 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,577 | 1,058 | $2.16 | $3,413 |
| 84153 Clinical Chemistry | 441 | 349 | $17.75 | $7,829 |
| 36415 Venipuncture Blood Collection | 432 | 345 | $8.65 | $3,737 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas K Slabaugh Jr. prescribed most often to Medicare patients was Alfuzosin Hcl Er (Alfuzosin Hcl), with 793 prescriptions and refills. In total Thomas K Slabaugh Jr. wrote 5,397 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alfuzosin Hcl Er Alfuzosin Hcl | 793 | 2,211 | 270 | $15K |
| Finasteride Generic | 706 | 1,944 | 230 | $7,811 |
| Tamsulosin Hcl Generic | 511 | 1,365 | 179 | $5,789 |
| Methenamine Hippurate Generic | 396 | 866 | 124 | $41K |
| Doxycycline Monohydrate Generic | 380 | 382 | 296 | $3,793 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 219 | 219 | 194 | $1,628 |
| Cefuroxime Cefuroxime Axetil | 170 | 170 | 149 | $3,094 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 168 | 177 | 123 | $3,001 |
| Doxycycline Hyclate Generic | 152 | 152 | 145 | $490 |
| Solifenacin Succinate Generic | 142 | 392 | 56 | $9,418 |
| Myrbetriq Mirabegron | 112 | 224 | 35 | $98K |
| Bicalutamide Generic | 104 | 242 | 40 | $4,490 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 99 | 251 | 36 | $3,207 |
| Gemtesa Vibegron | 90 | 244 | 38 | $116K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 80 | 80 | 78 | $456 |
Brand drugs: - claims; generic drugs: 5,032 claims; opioid claims: 324.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas K Slabaugh Jr. $62K ($62K in general payments such as food, travel and fees) from 28 companies. The largest payer was AngioDynamics, Inc. with $60K.
| Company | Payments | Amount |
|---|---|---|
| AngioDynamics, Inc. ANGO | 1 | $60K |
| Boston Scientific Corporation BSX | 11 | $578 |
| Procept Biorobotics Corporation PRCT | 2 | $223 |
| Accord Healthcare, Inc. | 5 | $185 |
| Telix Pharmaceuticals TLX | 2 | $163 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $140 |
| Pfizer Inc. PFE | 5 | $124 |
| Astellas Pharma US Inc 4503.T | 4 | $95.74 |
| Laborie Medical Technologies Corp. | 1 | $95.73 |
| Olympus America Inc. | 4 | $87.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.